|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Initiating insulin therapy with,or switching existing insulin therapy to,biphasic insulin aspart 30/70 (NovoMix 30) in routine care:safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study显示文摘 | Valensi P Benroubi M Borzi V | | 0，，： | 1 |
| 2 | Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix 30) when switching from human premix insulin in patients with type 2 diabetes:subgroup analysis from the 6-month IMPROVE observational study显示文摘 | Shah S Benroubi M Borzi V | | 0，，： | 1 |
| 3 | Characteristics of patients withtype 2 diabetes mellitus initiating insulin therapy: baseline data from theINSTIGATE study*显示文摘 | Jones S Benroubi M Castell C | 2009 | Current Medical Research and Opinion2009，25，3： | 1 |
| 4 | The IMPROVE study-a multinational,observational study in type 2 diabetes:baseline characteristics from eight national cohorts 显示文摘 | Valensi P Benroubi M Borzi V | 2008 | Int J Clin Pract2008，62，11： | 1 |
| 5 | The IMPROVE study-a multinational,observational study in type 2 diabetes:baseline characteristics from eight national cohorts显示文摘 | Valensi P Benroubi M Borzi V | | 0，，11： | 1 |
| 6 | Initiating insulin therapywith, or switching existing insulin therapy to, biphasic insulin aspart30/70 ( Novo Mixl 30) in routine care ; safety and effectiveness inpatients with type 2 diabetes in the IMPROVE observational study显示文摘 | Valensi P Benroubi M Borzi V | 2009 | International Journal of Clinical Practice2009，63，： | 1 |
| 7 | Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study*显示文摘 | Stephen Jones Marian Benroubi Conxa Castell Albert Goday Andreas Liebl Louise Timlin Claudia Nicolay Alexander Simpson Aodan Tynan | 2009 | Current Medical Research and Opinion2009，，3： | 1 |
| 8 | Clinical outcomes after insulin initiation in patients with type 2 diabetes: 6-month data from the INSTIGATE observational study in five European countries显示文摘 | Andreas Liebl Stephen Jones Marian Benroubi Conxa Castell Albert Goday Marie Aline Charles Helen T. Smith Claudia Nicolay Alexander Simpson | 2011 | Current Medical Research & Opinion2011，，5： | 1 |
| 9 | Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70(NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVETM observational study显示文摘 | Valensi P Benroubi M Borzi V | 2009 | Int J Clin Pract2009，63，3： | 1 |
| 10 | Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix 30) can improve glycaemic control in patients treated with basal in- sulins: a subgroup analysis of the IMPROVE observational study显示文摘 | Gumprecht J Benroubi M Borzi V | 2009 | International journal of clinical practice2009，63，6： | 1 |
| 11 | Safety and effectiveness of biphasic insulin aspart 30/70( NovoMix30)when switching from human premix insulin in patients with type 2 diabetes:subgroup analysis from the 6-month IMPROVETM observational study显示文摘 | Shah S Benroubi M Borzi V | | 0，，04： | 1 |
| 12 | Safety and effectiveness ofbiphasic insulin aspart 30/70 (NovoMix 30) when switching fromhuman premix insulin in patients with type 2 diabetes: subgroupanalysis from the 6-month IMPROVE observational study显示文摘 | Shah S Benroubi M Borzi V | 2009 | Int JClin Pract2009，63，4： | 1 |
| 13 | The IMPROVE study-a multinational,observational study in type 2 diabetes:baseline characteristics from eight national cohorts显示文摘 | Valensi P Benroubi M Borzi V | 2008 | Int J Clin Pract2008，62，11： | 1 |
| 14 | Initiating insulin therapy with,or switching existing insulin therapy to,biphasic insulin aspart 30/70 (NovoMix 30) in routine care:safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study显示文摘 | Valensi P Benroubi M Borzi V | | 0，，： | 1 |
| 15 | Improved glycaemic control with BIAsp 30 in insulin-na(i)ve type 2 diabetes patients inadequately controlled on oral antidiabetics:subgroup analysis from the IMPROVE study显示文摘 | Wenying Y Benroubi M Borzi V | | 0，，： | 1 |
| 16 | Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMixl 30)in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study 显示文摘 | Valensi P Benroubi M Borzi V | 2009 | Int J Clin Pract2009，63，2： | 1 |
| 17 | The IMPROVETM studya multinational,observational study in type 2 diabetes:baseline characteristics from eight national cohort显示文摘 | Valensi P Benroubi M Borzi V | | 0，，： | 1 |
| 18 | Safety and effectiveness ofbiphasic insulin aspart 30/70(NovoMix 30)when switching from hu-man penmix insulin in patients with type 2 diabetes:subgroup analysisfrom the 6-month improve observational study显示文摘 | Shah S Benroubi M Gumprecht J | 2009 | Int J Clin Pract2009，63，4： | 1 |
| 19 | Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 ( NovoMix 30 ) in routine care : safety and effectiveness in pa- tients with type 2 diabetes in the IMPROVE observational study 显示文摘 | Valensi P Benroubi M Borzi V | 2009 | Int J Clin Pract2009，63，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员